Evidence map›Paper›PMID 30514750›Full record

ArticleBlood2019

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.

Anusara Daenthanasanmak, Supinya Iamsawat, Paramita Chakraborty, Hung D Nguyen, David Bastian, Chen Liu, Shikhar Mehrotra, Xue-Zhong Yu

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Targeting PRMT1 prevents acute and chronic graft-versus-host disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Novel Role of the SIRT1 in Endocrine and Metabolic Diseases.International journal of biological sciences · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anusara DaenthanasanmakDepartment of Microbiology and Immunology and.
Supinya IamsawatDepartment of Microbiology and Immunology and.
Paramita ChakrabortyDepartment of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
Hung D NguyenDepartment of Microbiology and Immunology and.
David BastianDepartment of Microbiology and Immunology and.
Chen LiuDepartment of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; and.
Shikhar MehrotraDepartment of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
Xue-Zhong YuDepartment of Microbiology and Immunology and.
MUSC Hollings Cancer Center · USJohnson University · USMedical University of South Carolina · US

Funding

Effects of Foxp3-Induced Regulatory T Cells on GVHD and GVT ActivityR01CA118116 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, XUE-ZHONG · 2006 to 2015
$2.2M
MicroRNA Regulates Graft-versus-Host DiseaseR01AI118305 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, XUE-ZHONG · 2015 to 2019
$1.7M
Targeting IL-12/23 p40 Pathways for the Control of GVHDR01CA169116 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, XUE-ZHONG · 2013 to 2017
$1.6M
Separation of GVH and GVL Responses Using Alloreactive CD8 iTregsR01HL137373 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, XUE-ZHONG · 2017 to 2020
$1.5M
NCI NIH HHS R01 CA118116NCI NIH HHS R01 CA169116NHLBI NIH HHS R01 HL137373NIAID NIH HHS R01 AI118305
6 · The paper itself

Abstract

Graft-versus-host disease (GVHD) remains one of the major complications after allogeneic bone marrow transplantation (allo-BMT). Sirtuin-1 (Sirt-1) plays a crucial role in various biological processes including cellular senescence, metabolism, and inflammatory responses. Sirt-1 deacetylation regulates different transcription factors that are important for modulating immune responses. In the current study, we addressed the role of Sirt-1 in GVHD induction by employing Sirt-1 conditional knockout mice as well as a pharmacological Sirt-1 inhibitor. Using major histocompatibility complex (MHC)-mismatched and MHC-matched murine BMT models, we found that Sirt-1

Indexed as

AcetylationAnimalsB-LymphocytesBone Marrow TransplantationCarbazolesCell DifferentiationFemaleGraft vs Host DiseaseGraft vs Leukemia EffectLymphocyte ActivationMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutSirtuin 1T-Lymphocytes, Regulatory6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamideCarbazolesSirt1 protein, mouseSirtuin 1Trp53 protein, mouseTumor Suppressor Protein p53

Identifiers

PMID30514750
PMCPMC6337874
OpenAlexW2902058990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.